Coronary Artery Lesions,Primary
1 clinical trials · Condition
◉ Watch Coronary Artery Lesions,Primary
| Record | Firm | Date |
|---|---|---|
| Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization (NCT01681381) | Essen Technology (Beijing) Co., Ltd. | 2012-09-01 |
Track Coronary Artery Lesions,Primary automatically
Every clearance here is in the API, with alerts when new ones post.